JPWO2023150759A5 - - Google Patents
Info
- Publication number
- JPWO2023150759A5 JPWO2023150759A5 JP2024546294A JP2024546294A JPWO2023150759A5 JP WO2023150759 A5 JPWO2023150759 A5 JP WO2023150759A5 JP 2024546294 A JP2024546294 A JP 2024546294A JP 2024546294 A JP2024546294 A JP 2024546294A JP WO2023150759 A5 JPWO2023150759 A5 JP WO2023150759A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- composition
- subject
- dinitrophenoxy
- imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263307470P | 2022-02-07 | 2022-02-07 | |
| US63/307,470 | 2022-02-07 | ||
| US202263382426P | 2022-11-04 | 2022-11-04 | |
| US63/382,426 | 2022-11-04 | ||
| PCT/US2023/062065 WO2023150759A1 (en) | 2022-02-07 | 2023-02-06 | Methods of weight loss in a subject with elevated hba1c |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025505632A JP2025505632A (ja) | 2025-02-28 |
| JP2025505632A5 JP2025505632A5 (https=) | 2026-02-16 |
| JPWO2023150759A5 true JPWO2023150759A5 (https=) | 2026-02-16 |
Family
ID=85569618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024546294A Pending JP2025505632A (ja) | 2022-02-07 | 2023-02-06 | 上昇したＨｂＡ１ｃを有する対象における体重減少の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250134865A1 (https=) |
| EP (1) | EP4475842A1 (https=) |
| JP (1) | JP2025505632A (https=) |
| KR (1) | KR20240146053A (https=) |
| AU (1) | AU2023214495A1 (https=) |
| CA (1) | CA3243643A1 (https=) |
| IL (1) | IL314682A (https=) |
| MX (1) | MX2024009644A (https=) |
| WO (1) | WO2023150759A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3565806T (pt) | 2017-01-06 | 2022-05-19 | Rivus Pharmaceuticals Inc | Novos derivados de fenilo |
| WO2022246039A1 (en) * | 2021-05-20 | 2022-11-24 | Rivus Pharmaceuticals, Inc. | Methods of treating mitochondria-related disorders |
-
2023
- 2023-02-06 WO PCT/US2023/062065 patent/WO2023150759A1/en not_active Ceased
- 2023-02-06 US US18/835,578 patent/US20250134865A1/en active Pending
- 2023-02-06 IL IL314682A patent/IL314682A/en unknown
- 2023-02-06 JP JP2024546294A patent/JP2025505632A/ja active Pending
- 2023-02-06 CA CA3243643A patent/CA3243643A1/en active Pending
- 2023-02-06 KR KR1020247029814A patent/KR20240146053A/ko active Pending
- 2023-02-06 MX MX2024009644A patent/MX2024009644A/es unknown
- 2023-02-06 EP EP23710591.1A patent/EP4475842A1/en active Pending
- 2023-02-06 AU AU2023214495A patent/AU2023214495A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8653136B2 (en) | Compositions based on amino acids for improving the myocardial ventricular function in patients suffering from diabetes | |
| Auvinet et al. | Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients in acute sciatica | |
| KR20160136451A (ko) | Nafld 및 nash 의 치료 | |
| JP2001509173A (ja) | 胃腸リパーゼ阻害剤の使用 | |
| US10363235B2 (en) | Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same | |
| CA2620065A1 (en) | Methods and formulations for modulating lyn kinase activity and treating related disorders | |
| JPWO2023150759A5 (https=) | ||
| WO2018163119A1 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| JPWO2023150767A5 (https=) | ||
| JP4355967B2 (ja) | 医薬組成物 | |
| JP2025513289A5 (https=) | ||
| Imai et al. | Do the effects of long-term lomerizine administration differ with age? | |
| JP7508447B2 (ja) | 血糖制御を改善し、炎症性腸疾患を処置するための構造修飾脂肪酸 | |
| KR102916453B1 (ko) | 오바토클락스 대사성 질환 및 섬유화 질환 치료 용도 | |
| JP2024015394A (ja) | 肥満改善剤 | |
| JP2021520403A (ja) | 糖尿病予防・治療用の医薬品組成物及びその用途 | |
| JP2024090481A (ja) | 脂肪化抑制剤および脂肪関連疾患の予防又は治療に使用するための医薬組成物 | |
| Singh et al. | A CLINICAL COMPARATIVE STUDY OF SOME VISHAGHNA DRAVAYA AND ERAND TAIL IN THE MANAGEMENT OF AMAVATA | |
| CN102614382A (zh) | 一种用于治疗帕金森病的中药组合物及制备方法和用途 | |
| CN116712420A (zh) | 一种花椒酰胺在制备治疗多发性硬化症的药物中的应用 | |
| KR20240146053A (ko) | 상승된 HbA1c를 갖는 대상체에서의 체중 감소 방법 | |
| JPWO2022246039A5 (https=) | ||
| JP2009196996A (ja) | 医薬組成物 | |
| JPWO2022249071A5 (https=) | ||
| HK40025703A (en) | Mpges-1 inhibitor for the treatment of osteoarthritis pain |